Population Pharmacokinetics of Ciprofloxacin in Neonates and Young Infants Less than Three Months of Age

Ciprofloxacin is used in neonates with suspected or documented Gram-negative serious infections. Currently, its use is off-label partly because of lack of pharmacokinetic studies. Within the FP7 EU project TINN (Treat Infection in NeoNates), our aim was to evaluate the population pharmacokinetics of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antimicrob Agents Chemother
Glavni autori: Zhao, Wei, Hill, Helen, Le Guellec, Chantal, Neal, Tim, Mahoney, Sarah, Paulus, Stephane, Castellan, Charlotte, Kassai, Behrouz, van den Anker, Johannes N., Kearns, Gregory L., Turner, Mark A., Jacqz-Aigrain, Evelyne
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2014
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249352/
https://ncbi.nlm.nih.gov/pubmed/25155587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03568-14
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items